DR
Deepa Rani
About Deepa Rani
Data last updated:
Deepa Rani is a Director at Sanya Pharma Private Limited (since 2011) and Director at Winshire Agencies Pvt Ltd (since 2013). The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹47.46 Cr; the largest is Sanya Pharma Private Limited at ₹46.59 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanya Pharma Private Limited U24231WB1997PTC082733 | Director | 28 Nov 2011 | 1997 | ₹46.59 Cr (FY 2025) | Active |
 Winshire Agencies Pvt Ltd U51909WB1996PTC078224 | Director | 09 Oct 2013 | 1996 | ₹87.5 Lakh (FY 2024) | Active |
Board colleagues of Deepa Rani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar | 00940372 | Sanya Pharma Private Limited , Winshire Agencies Pvt Ltd | Director |
| Asmita Dalmia | 11548398 | Sanya Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepa Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepa Rani
Deepa Rani currently holds 2 directorships: Sanya Pharma Private Limited (Director, since 28 Nov 2011, revenue ₹46.59 Cr (FY 2025)); Winshire Agencies Pvt Ltd (Director, since 09 Oct 2013, revenue ₹87.5 Lakh (FY 2024)).
Deepa Rani was first appointed on 28 Nov 2011 as Director at Sanya Pharma Private Limited. The most recent appointment on record is 09 Oct 2013 at Winshire Agencies Pvt Ltd.
The 2 current companies of Deepa Rani that report revenue have a combined latest revenue of ₹47.46 Cr: Sanya Pharma Private Limited ₹46.59 Cr (FY 2025); Winshire Agencies Pvt Ltd ₹87.5 Lakh (FY 2024).
The current boards of Deepa Rani's companies include Arvind Kumar (Sanya Pharma Private Limited), Asmita Dalmia (Sanya Pharma Private Limited).